OVUPLANT DIN 02159708
Status: Cancelled Post Market
Holder: PEPTECH ANIMAL HEALTH PTY LTD.
Molecule: DESLORELIN (DESLORELIN ACETATE)
Available to quote
Health Canada record
| Active ingredient(s) | DESLORELIN (DESLORELIN ACETATE) 2.1 MG |
|---|---|
| Dosage form | Implant |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1996 |
| Current status date | 25-Aug-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Peptech Animal Health Pty Limited - Wholly owned subsidiary of Virbac (Australia) Pty Ltd — licence , not currently licensed, last inspection rating C (2022-11-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DESLORELIN (DESLORELIN ACETATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02426404 | SUCROMATE EQUINE | DECHRA REGULATORY BV | Suspension | DESLORELIN (DESLORELIN ACETATE) 1.7 MG | Approved |
| 02526689 | SUPRELORIN 4.7 MG IMPLANT | VIRBAC AH, INC. | Implant | DESLORELIN (DESLORELIN ACETATE) 4.7 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6125 | 2002-02-27 | Supplement to a New Drug Submission (SNDS) | ALTERNATE SOURCE OF ACTIVE INGREDIENT |
| 6265 | 2000-10-13 | Supplement to a New Drug Submission (SNDS) | CHANGE IN EXPIRY DATE AND CHANGE IN SPECIFICATIONS |
| 6877 | 1998-02-26 | New Drug Submission (NDS) | |
| 7521 | 1995-03-16 | New Drug Submission (NDS) |